The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127026051 12702605 1 I 20160621 20160622 20160831 20160831 PER US-JNJFOC-20160704043 JANSSEN 50.32 YR A F Y 120.66000 KG 20160831 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127026051 12702605 1 SS STELARA USTEKINUMAB 1 Subcutaneous N FKS03MC;FKS03MC 0 90 MG SOLUTION FOR INJECTION
127026051 12702605 2 PS STELARA USTEKINUMAB 1 Subcutaneous N FKS03MC;FKS03MC 125261 90 MG SOLUTION FOR INJECTION
127026051 12702605 3 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Unknown 0 50 MG UNSPECIFIED
127026051 12702605 4 C ATORVASTATIN ATORVASTATIN 1 Unknown 0 40 MG UNSPECIFIED
127026051 12702605 5 C FENOFIBRATE. FENOFIBRATE 1 Unknown 0 134 MG UNSPECIFIED
127026051 12702605 6 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 0 1000 MG UNSPECIFIED
127026051 12702605 7 C POTASSIUM POTASSIUM 1 Unknown SUPPLEMENT 0 40 MEQ UNSPECIFIED
127026051 12702605 8 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 0 5 MG UNSPECIFIED
127026051 12702605 9 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown INDIGESTION 0 40 MG UNSPECIFIED
127026051 12702605 10 C MAGNESIUM MAGNESIUM 1 Unknown SUPPLEMENT 0 400 MG UNSPECIFIED
127026051 12702605 11 C DULOXETINE. DULOXETINE 1 Unknown 0 60 MG UNSPECIFIED
127026051 12702605 12 C DULOXETINE. DULOXETINE 1 Unknown 0 60 MG UNSPECIFIED
127026051 12702605 13 C LEVEMIR INSULIN DETEMIR 1 Subcutaneous 0 60 MG UNSPECIFIED
127026051 12702605 14 C VICTOZA LIRAGLUTIDE 1 Unknown 0 1.8 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127026051 12702605 1 Psoriasis
127026051 12702605 2 Psoriatic arthropathy
127026051 12702605 3 Hypertension
127026051 12702605 4 Blood cholesterol increased
127026051 12702605 5 Blood cholesterol increased
127026051 12702605 6 Diabetes mellitus
127026051 12702605 8 Hypertension
127026051 12702605 11 Pain
127026051 12702605 12 Diabetes mellitus
127026051 12702605 13 Diabetes mellitus
127026051 12702605 14 Diabetes mellitus

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127026051 12702605 Drug dose omission
127026051 12702605 Incorrect product storage
127026051 12702605 Syringe issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127026051 12702605 4 2013 0
127026051 12702605 5 2014 0
127026051 12702605 6 2013 0
127026051 12702605 7 2014 0
127026051 12702605 8 2015 0
127026051 12702605 9 2006 0
127026051 12702605 10 2015 0
127026051 12702605 13 2013 0
127026051 12702605 14 2013 0